Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Hematology (blood)

  • 1
    News

    Trends in the management of pulmonary embolism

    May 7, 2021

    After completion of primary treatment for patients with unprovoked DVT and/or PE, guidelines suggest indefinite antithrombotic therapy over stopping anticoagulation.

  • News

    AHA guidance on blood clots linked to COVID-19 vaccine

    April 30, 2021

    “The risk of CVST due to infection with COVID-19 is 8-10 times higher than the risk of CVST after receiving a COVID-19 vaccine.”

  • News

    How some COVID-19 vaccines could cause rare blood clots

    April 14, 2021

    Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.

  • News

    Novel antiplatelet drug: Hope for efficacy without bleeding?

    April 12, 2021

    A new antiplatelet drug with a completely novel mechanism of action could hold the promise of delivering the holy grail – reducing cardiac events without increasing bleeding.

  • 1
    News

    DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes

    February 2, 2021

    In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT) with aspirin and ticagrelor on cardiovascular outcomes and bleeding events?

  • 1
    News

    Anticoagulation and antiplatelet therapy after GI bleed cut mortality, ischemic events

    January 28, 2021

    In patients who present with a gastrointestinal bleed (GIB) while on an anticoagulants (AC) or antiplatelets (AP), what are the risks and benefits to resuming these medications?

  • News

    Doctors search for missing link between COVID-19 and ITP

    January 28, 2021

    “We don’t know much about platelet counts in COVID-19 at all.”

  • News

    Full-dose anticoagulation reduces need for life support in COVID-19

    January 25, 2021

    “We have treatments that are improving outcomes but not as many that reduce mortality, so we’re hopeful when the full dataset comes in that will be confirmed.”

  • 1
    News

    DOACs show safety benefit in early stages of CKD

    January 15, 2021

    In terms of efficacy and bleeding risk, what is known about anticoagulation in patients with chronically impaired renal function?

  • News

    In COVID-19 patients, risk of bleeding rivals risk of thromboembolism

    January 12, 2021

    Trials are urgently needed to define optimal anticoagulation strategies for COVID-19 infection.

Previous1 2 3 4 5 6 … 13Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences